Mutares Stock Sinks to 52-Week Low as €450 Million SABIC Deal and Debt Deadline Converge

The Munich-based investment firm Mutares is navigating a period of stark contrasts. While the company pushes ahead with the largest acquisition in its history and targets a near-tripling of group revenue by 2028, its shares have tumbled to a fresh 52-week low of €23.50, shedding more than a fifth of their value since the start of the year. The stock has lost roughly 25% in the past month alone.

The sell-off reflects mounting balance-sheet pressure rather than operational weakness. At the end of last year, Mutares breached a net debt covenant, prompting management to seek a waiver from bondholders through the end of June 2026. A repayment plan has been put in place, with regular tranches of the outstanding bond to be bought back starting in the second quarter. The recently completed capital increase — which raised €105 million gross through the issuance of roughly 4.3 million new shares at €24.50 apiece — is intended to shore up the balance sheet. About 80% of those proceeds are earmarked for growth in the US and Europe.

SABIC Deal Moves Forward

The centerpiece of Mutares’ expansion strategy is the planned acquisition of SABIC’s engineering thermoplastics (ETP) business. The transaction, valued at around $450 million, would be the largest in the firm’s history. The target, which produces specialty plastics and generates annual revenue in the billions, operates facilities in the US. Closing is expected in the second half of this year, subject to regulatory approvals, with Mutares targeting a completion date in June or July 2026.

The ETP business is slated to form the core of a new “Chemicals & Materials” segment. However, Mutares has signaled that significant restructuring lies ahead. Management has not ruled out the closure of the Spanish site in Cartagena as part of those efforts.

Amaneos IPO Pushed Back

Separately, the planned initial public offering of automotive supplier Amaneos has been pushed to 2027 or 2028. Mutares is pursuing a dual-track strategy, also weighing a direct sale of the subsidiary. Amaneos generated €1.1 billion in revenue in 2024 and was operationally profitable.

Should investors sell immediately? Or is it worth buying Mutares?

Rapid Portfolio Turnover

Beyond the SABIC deal, the dealmaking machine continues to turn at high speed. In mid-April, Mutares announced the sale of inTime Group, a logistics company that had been in the portfolio for just eight months after its purchase last August. On the buying side, two divisions of automotive supplier Magna — its lighting and roof systems businesses — are nearing integration, bringing combined additional annual revenue of more than $300 million. The transaction is expected to close in the current second quarter.

Revenue Targets and Analyst Optimism

Despite the balance-sheet strain, the underlying business is delivering robust numbers. Group revenue climbed to €6.5 billion in the last fiscal year, while the holding company’s net profit rose to more than €130 million. Management forecasts another leap this year, with revenue reaching as high as €9.1 billion. The medium-term target calls for annual growth of 25% through 2030, with a longer-term goal of €10 billion in group revenue by 2028.

Analysts remain broadly bullish despite the share price weakness. Warburg Research has a “Buy” rating with a €46 price target, while Jefferies sees fair value at €37. The consensus target stands at €43.50, implying upside of roughly 85% from current levels.

Key Dates Ahead

Investors have several milestones to watch. On April 28, Mutares will publish its audited annual report for 2025, which will provide clarity on the holding company’s true profitability and the progress of portfolio exits. New shares from the subscription tranche will also be delivered to investors that day. First-quarter results are due on May 12, and the annual general meeting on July 3 will decide on dividend payments for the past year.